Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Endometrial Neoplasms 1Depressive Disorder 1Colorectal Neoplasms 1Colonic Neoplasms 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 16Bevacizumab 12Carboplatin 10Nivolumab 8Pemetrexed 7Temozolomide 6Standard of Care 6Exercise 6Cetuximab 6durvalumab 5atezolizumab 5Prednisone 5Cyclophosphamide 5abemaciclib 4Paclitaxel 4Doxorubicin 4Dexamethasone 4Cisplatin 4Blood Specimen Collection 4temsirolimus 3enzalutamide 3dostarlimab 3daratumumab 3cabozantinib 3Sunitinib 3Rituximab 3Oxaliplatin 3Metformin 3Leucovorin 3Lenalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Counseling × 30 days × Clear all
NCT06184256 2026-05-18

BfedBwell Optimization Pilot

University of Colorado, Denver

Phase NA Active not recruiting
73 enrolled
Other

Motor Activity, Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡